Continuous and Bi-level positive airway pressure for motion mitigation of intra-thoracic tumors treated with radiotherapy
Recruiting
- Conditions
- esophageal cancer1001799010038666lung cancer
- Registration Number
- NL-OMON49188
- Lead Sponsor
- Radiotherapie (DA30)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 31
Inclusion Criteria
Intra-thoracic malignancy (locoregionally advanced stage lung cancer,
esophageal cancer or malignant lymphoma) that wil be treated with curative
intent with radiotherapy. Informed consent needs te bo obtained. Age: 18 years
or older.
Exclusion Criteria
• Facial deformations so that facial mask are impossible to fit
• Noncompliance with any of the inclusion criteria.
• Planned for radiotherapy with fraction dose >=3 Gy.
• Severe heart failure (LVEF<30%)
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary endpoint is the effect of CPAP or BiPAP on tumor motion (tumor<br /><br>amplitude expressed in millimeters) during the course of radiotherapy. </p><br>
- Secondary Outcome Measures
Name Time Method